Severin Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Severin Investments's BMY Position: Q2 2026 in Review
Severin Investments increased its Bristol-Myers Squibb (BMY) stake by 4.1% in Q2 2026, buying an estimated $15.8K and bringing the position to 7,029 shares worth $405K. The position accounts for 0.31% of the portfolio, ranked #122.
Severin Investments first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $601K in Q2 2025. 2,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Severin Investments held 7,029 shares of Bristol-Myers Squibb worth $405K as of Q2 2026.
- Severin Investments bought 275 Bristol-Myers Squibb shares in Q2 2026, an estimated $15.8K.
- Bristol-Myers Squibb made up 0.31% of Severin Investments's portfolio in Q2 2026, its #122 holding.
- Severin Investments first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Severin Investments's Bristol-Myers Squibb position peaked at $601K in Q2 2025.
- 2,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Severin Investments's 13F filing for Q2 2026, filed 14 Aug 2026.